Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Fruzaqla Adds Sparkle To Takeda’s First Half
Pen Helps Mainstay Entyvio
Nov 01 2024
•
By
Ian Haydock
Japan now only 10% of Takeda's revenues but firm says it's committed to home market • Source: Takeda
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Scrip
More from Focus On Asia